ANO1

From WikiMD's Wellness Encyclopedia

ANO1 (Anoctamin 1), also known as TMEM16A (transmembrane protein 16A), is a protein that in humans is encoded by the ANO1 gene. ANO1 is a member of the anoctamin family of proteins, which are characterized by their ability to function as calcium-activated chloride channels (CaCCs). These channels play a critical role in various physiological processes, including muscle contraction, sensory perception, and epithelial secretion.

Function[edit | edit source]

ANO1 is widely expressed in different tissues of the body and is involved in a variety of cellular functions. As a calcium-activated chloride channel, it helps regulate the flow of chloride ions across cell membranes in response to increases in intracellular calcium levels. This activity is essential for several physiological processes:

  • In smooth muscle cells, ANO1 facilitates muscle contraction by depolarizing the cell membrane in response to calcium signals.
  • In sensory neurons, it is involved in the transduction of thermal and nociceptive (pain) signals.
  • In epithelial cells, ANO1 contributes to fluid secretion, such as mucus production in airways and saliva in salivary glands.

Clinical Significance[edit | edit source]

ANO1 has been implicated in a variety of diseases and disorders. Its overexpression has been observed in several types of cancer, including gastrointestinal stromal tumors (GISTs), breast cancer, and prostate cancer, suggesting a potential role in tumorigenesis and cancer progression. Inhibitors of ANO1 are being studied as possible therapeutic agents for these cancers.

Furthermore, mutations in the ANO1 gene have been associated with certain genetic disorders. For example, alterations in ANO1 function can affect cystic fibrosis transmembrane conductance regulator (CFTR) activity, impacting cystic fibrosis disease mechanisms.

Research[edit | edit source]

Research on ANO1 is ongoing, with studies aimed at understanding its precise mechanisms of action, its role in health and disease, and its potential as a target for therapeutic intervention. The development of specific inhibitors and activators of ANO1 is a focus of research, with the goal of exploiting these molecules for the treatment of diseases such as cancer, pain, hypertension, and cystic fibrosis.

See Also[edit | edit source]


WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD